Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. 2009

Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
Department of Biological Chemistry and Molecular Pharmacology, and Infectious Diseases Division, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. jeremy.kamil@gmail.com

Several different families of DNA viruses encode proteins that inactivate the cellular retinoblastoma tumor suppressor protein (pRb), which normally functions to bind E2F transcription factors and restrict expression of genes necessary for cellular processes including DNA replication. Human cytomegalovirus (HCMV) UL97, a protein kinase functionally orthologous to cellular cyclin-dependent kinases, phosphorylates pRb on inactivating residues during HCMV infection. To assess if such phosphorylation is biologically relevant, we tested whether the human papillomavirus type 16 E7 protein, which inactivates pRb family proteins by direct binding and destabilization, could substitute for UL97 during HCMV infection. In the absence of UL97, expression of wild-type E7 protein, but not a mutant E7 unable to bind pRb family proteins, restored E2F-responsive cellular gene expression, late viral gene expression, and viral DNA synthesis to levels normally observed during wild-type virus infection of quiescent cells. UL97-null mutants exhibited more pronounced defects in virus production and DNA synthesis in quiescent cells as compared to serum-fed, cycling cells. E7 expression substantially enhanced infectious virus production in quiescent cells, but did not complement the defects observed during UL97-null virus infection of cycling cells. Thus, a primary role of UL97 is to inactivate pRb family proteins during infection of quiescent cells, and this inactivation likely abets virus replication by induction of cellular E2F-responsive genes. Our findings have implications for human cytomegalovirus disease and for drugs that target UL97.

UI MeSH Term Description Entries
D009856 Oncogene Proteins, Viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Viral Oncogene Proteins,Viral Transforming Proteins,v-onc Proteins,Transforming Proteins, Viral,v onc Proteins
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016160 Retinoblastoma Protein Product of the retinoblastoma tumor suppressor gene. It is a nuclear phosphoprotein hypothesized to normally act as an inhibitor of cell proliferation. Rb protein is absent in retinoblastoma cell lines. It also has been shown to form complexes with the adenovirus E1A protein, the SV40 T antigen, and the human papilloma virus E7 protein. Rb Protein,Retinoblastoma Nuclear Phosphoprotein p105-Rb,p105-Rb Protein,Rb Gene Product,Rb1 Gene Product,Retinoblastoma Nuclear Phosphoprotein p105 Rb,p105 Rb Protein
D050725 Papillomavirus E7 Proteins ONCOGENE PROTEINS from papillomavirus that deregulate the CELL CYCLE of infected cells and lead to NEOPLASTIC CELL TRANSFORMATION. Papillomavirus E7 proteins have been shown to interact with various regulators of the cell cycle including RETINOBLASTOMA PROTEIN and certain cyclin-dependent kinase inhibitors. E7 Oncogene Proteins,Oncogene Protein E7, Papillomavirus,E7 Proteins, Papillomavirus,Oncogene Proteins, E7
D017853 Phosphotransferases (Alcohol Group Acceptor) A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.

Related Publications

Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
June 2006, Cancer research,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
May 1992, Molecular and cellular biology,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
July 1992, The EMBO journal,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
February 1993, Molecular and cellular biology,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
March 1994, The Journal of biological chemistry,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
April 2017, The Journal of biological chemistry,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
September 1999, Molecular and cellular biology,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
October 1989, The New biologist,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
February 2000, Oncogene,
Jeremy P Kamil, and Adam J Hume, and Igor Jurak, and Karl Münger, and Robert F Kalejta, and Donald M Coen
January 1993, The Journal of general virology,
Copied contents to your clipboard!